The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males.
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males.
复制标题
TLR3中L412F多态性抑制自噬,是男性严重COVID-19的标志。
DOI:
10.1080/15548627.2021.1995152
复制
发表时间:
2022-07
期刊:
影响因子:
13.3
通讯作者:
Meloni, Ilaria
中科院分区:
文献类型:
--
作者:
Croci, Susanna;Venneri, Mary Anna;Mantovani, Stefania;Fallerini, Chiara;Benetti, Elisa;Picchiotti, Nicola;Campolo, Federica;Imperatore, Francesco;Palmieri, Maria;Daga, Sergio;Gabbi, Chiara;Montagnani, Francesca;Beligni, Giada;Farias, Ticiana D. J.;Carriero, Miriam Lucia;Di Sarno, Laura;Alaverdian, Diana;Aslaksen, Sigrid;Cubellis, Maria Vittoria;Spiga, Ottavia;Baldassarri, Margherita;Fava, Francesca;Norman, Paul J.;Frullanti, Elisa;Isidori, Andrea M.;Amoroso, Antonio;Mari, Francesca;Furini, Simone;Mondelli, Mario U.;Chiariello, Mario;Renieri, Alessandra;Meloni, Ilaria
The polymorphism L412F in TLR3 has been associated with several infectious diseases. However, the mechanism underlying this association is still unexplored. Here, we show that the L412F polymorphism in TLR3 is a marker of severity in COVID-19. This association increases in the sub-cohort of males. Impaired macroautophagy/autophagy and reduced TNF/TNFα production was demonstrated in HEK293 cells transfected with TLR3L412F-encoding plasmid and stimulated with specific agonist poly(I:C). A statistically significant reduced survival at 28 days was shown in L412F COVID-19 patients treated with the autophagy-inhibitor hydroxychloroquine (p = 0.038). An increased frequency of autoimmune disorders such as co-morbidity was found in L412F COVID-19 males with specific class II HLA haplotypes prone to autoantigen presentation. Our analyses indicate that L412F polymorphism makes males at risk of severe COVID-19 and provides a rationale for reinterpreting clinical trials considering autophagy pathways. Abbreviations: AP: autophagosome; AUC: area under the curve; BafA1: bafilomycin A1; COVID-19: coronavirus disease-2019; HCQ: hydroxychloroquine; RAP: rapamycin; ROC: receiver operating characteristic; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; TLR: toll like receptor; TNF/TNF-α: tumor necrosis factor
登录
查看更多内容
影响因子:
4.6
作者:
Guo L;Yu H;Gu W;Luo X;Li R;Zhang J;Xu Y;Yang L;Shen N;Feng L;Wang Y
通讯作者:
Wang Y
影响因子:
3.9
作者:
Aslaksen, Sigrid;Wolff, Anette B.;Bratland, Eirik
通讯作者:
Bratland, Eirik
影响因子:
7.3
作者:
Keller CW;Lünemann JD
通讯作者:
Lünemann JD
影响因子:
2.2
作者:
Ayele Mega T;Feyissa TM;Dessalegn Bosho D;Kumela Goro K;Zeleke Negera G
通讯作者:
Zeleke Negera G
影响因子:
5.3
作者:
Gao T;Zhang SP;Wang JF;Liu L;Wang Y;Cao ZY;Hu QK;Yuan WJ;Lin L
通讯作者:
Lin L